EverEx

EverEx

AI-powered digital therapeutics for musculoskeletal rehabilitation.

HQ location
South Korea
Launch date
Employees
Enterprise value
$27—40m
Company register number
7518701409
Notes (0)
More about EverEx
Made with AI
Edit

EverEx is a digital healthcare company founded in August 2019 by Dr. Chan Yoon, an orthopedic surgeon. Witnessing the unmet needs in rehabilitation therapy during his 10 years of clinical practice, Dr. Yoon established EverEx to provide accessible, personalized rehabilitation for patients with musculoskeletal (MSK) disorders. The company is headquartered in Seoul, South Korea.

EverEx has developed the MORA (Mobile Orthopedic Rehabilitation Assistant) platform, a suite of digital solutions designed to support both patients and clinicians. The core of MORA is its proprietary AI-powered motion analysis technology, which uses the camera on a mobile device to assess a patient's movements, posture, and balance without requiring extra wearable sensors. The platform includes several products: MORA Vu for AI-based assessment, MORA Ex for customized remote rehabilitation exercises, MORA Cure which combines exercise with cognitive behavioral therapy as a prescription digital therapeutic, and MORA Care for corporate wellness programs. For clinicians, the platform provides a dashboard to monitor patient progress, assign tailored exercise programs from a library of over 3,000 exercises, and provide timely feedback. For patients, it offers a mobile application with guided exercise curriculums.

The company's business model focuses on providing its solutions to healthcare institutions. In the U.S., its 'EverEx Rehab' product is registered as a Class II medical device with the FDA and is structured to align with Remote Therapeutic Monitoring (RTM) billing codes, allowing clinics to get reimbursed for monitoring patient progress remotely. In South Korea, MORA Vu received Class II medical device approval, and MORA Cure was designated as the country's first innovative medical device for musculoskeletal disorders. EverEx has raised a total of approximately 25 billion won (around $18.8M USD). Its funding rounds include a $5.95M Series A in May 2023 and a $10.7M Series B in mid-2025, with investors like Premier Partners, Samsung NEXT, Hana Ventures, and Korea Development Bank.

Keywords: digital therapeutics, musculoskeletal, AI motion analysis, rehabilitation platform, orthopedic, remote therapeutic monitoring, pose estimation, MORA, physical therapy, digital healthcare, Chan Yoon, medical software, exercise therapy, patient monitoring, telehealth, healthcare technology, Class II medical device, cognitive behavioral therapy, corporate wellness

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads